SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-016632
Filing Date
2023-10-23
Accepted
2023-10-23 17:16:56
Documents
66
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20230831x10q.htm   iXBRL 10-Q 1520798
2 EX-10.1 cydy-20230831xex10d1.htm EX-10.1 122112
3 EX-31.1 cydy-20230831xex31d1.htm EX-31.1 9324
4 EX-31.2 cydy-20230831xex31d2.htm EX-31.2 9461
5 EX-32 cydy-20230831xex32.htm EX-32 4983
  Complete submission text file 0001558370-23-016632.txt   6973515

Data Files

Seq Description Document Type Size
6 EX-101.SCH cydy-20230831.xsd EX-101.SCH 56497
7 EX-101.CAL cydy-20230831_cal.xml EX-101.CAL 46921
8 EX-101.DEF cydy-20230831_def.xml EX-101.DEF 249314
9 EX-101.LAB cydy-20230831_lab.xml EX-101.LAB 376214
10 EX-101.PRE cydy-20230831_pre.xml EX-101.PRE 381429
60 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20230831x10q_htm.xml XML 1154131
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 231340591
SIC: 2834 Pharmaceutical Preparations